WAYRILZ
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
58468-0251 -
Package NDC
58468-0251-5 -
Package NDC
58468-0251-6 -
Application number
NDA219685 -
SPL ID
aa3b7d8a-0e0d-481b-bd36-4befaceba422 -
SPL set ID
95ffd367-9b0c-4f75-8487-5d8f3c0a5ad0 -
UNII
NWN58M4F5T -
RxCUI
2722403 -
RxCUI
2722409
What the source publishes
- Labeler
- Genzyme Corporation
- Active ingredients
- rilzabrutinib
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "WAYRILZ",
"splId": "aa3b7d8a-0e0d-481b-bd36-4befaceba422",
"labels": [
{
"setId": "95ffd367-9b0c-4f75-8487-5d8f3c0a5ad0",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=95ffd367-9b0c-4f75-8487-5d8f3c0a5ad0",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=95ffd367-9b0c-4f75-8487-5d8f3c0a5ad0"
}
],
"routes": [
"ORAL"
],
"labeler": "Genzyme Corporation",
"finished": true,
"packaging": [
{
"sample": false,
"description": "2 BLISTER PACK in 1 CARTON (58468-0251-5) / 28 TABLET, FILM COATED in 1 BLISTER PACK (58468-0251-0)",
"package_ndc": "58468-0251-5",
"identifierStatus": "well-formed",
"marketing_start_date": "20250829"
},
{
"sample": false,
"description": "1 BOTTLE in 1 CARTON (58468-0251-6) / 60 TABLET, FILM COATED in 1 BOTTLE",
"package_ndc": "58468-0251-6",
"identifierStatus": "well-formed",
"marketing_start_date": "20250829"
}
],
"productId": "58468-0251_aa3b7d8a-0e0d-481b-bd36-4befaceba422",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "58468-0251",
"deaSchedule": null,
"genericName": "rilzabrutinib",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "RILZABRUTINIB",
"strength": "400 mg/1"
}
],
"applicationNumber": "NDA219685",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20250829",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175605",
"N0000193934",
"N0000190114",
"N0000185503",
"N0000190113",
"N0000190107",
"N0000190108",
"N0000193845"
],
"unii": [
"NWN58M4F5T"
],
"rxcui": [
"2722403",
"2722409"
],
"spl_set_id": [
"95ffd367-9b0c-4f75-8487-5d8f3c0a5ad0"
],
"pharm_class_epc": [
"Kinase Inhibitor [EPC]"
],
"pharm_class_moa": [
"Bruton's Tyrosine Kinase Inhibitors [MoA]",
"Cytochrome P450 3A Inhibitors [MoA]",
"P-Glycoprotein Inhibitors [MoA]",
"Breast Cancer Resistance Protein Inhibitors [MoA]",
"Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
"Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
"Bile Salt Export Pump Inhibitors [MoA]"
],
"manufacturer_name": [
"Genzyme Corporation"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:58468-0251_aa3b7d8a-0e0d-481b-bd36-4befaceba422"